China National Center for Adverse Drug Reaction (ADR) Monitoring compiles the Guide Manual for Filling in the Cosmetic Adverse Reactions Report Form. The Guide Manual clarifies the filling-in requirements for two types of adverse reaction reports, individual cases of adverse reactions, and adverse reactions that may cause greater social impact.
On October 1, 2022, with the implementation of Measures for the Management of Cosmetic Adverse Reaction Monitoring, China NMPA launched the upgraded new version of the National Cosmetic Adverse Reaction Monitoring System (hereinafter referred to as “system”) to facilitate stakeholders to submit reports. Where cosmetic registrants, notifiers, entrusted production enterprises, operators, and/or medical institutions find or learn any cosmetic adverse reaction, they shall submit a report through the adverse reaction monitoring system.
Regarding the filling-in requirements for the adverse reaction report form, the Center for Drug Reevaluation, NMPA and National Center for Adverse Drug Reaction (ADR) Monitoring sent a Guide Manual for Filling in the Cosmetic Adverse Reaction Report Form (hereinafter referred to as “Guide Manual”) to provincial centers for adverse reaction monitoring on September 23, 2022, and published it on the system’s homepage.
[Read more at ChemLinked]
Reference Links
FAQs | Questions on Cosmetic Labelling Clarified by China NMPA
Contact Us
We are devoted to providing professional global market access consultations and customized regulatory compliance services for cosmetic companies. If you need any help with cosmetic regulatory compliance in China, please feel free to contact us. Tel: +86-571-87103817 Email: customer@reach24h.com
